维生素A补充剂和儿童存活率
M G Herrera1, P Nestel, A el Amin
1Harvard Institute for International Development, Cambridge, Massachusetts 02138.
Lancet (London, England)
|August 1, 1992
概括
每六个月高剂量维生素A补充剂并没有减少苏丹的儿童死亡率. 贫困,卫生条件差,饮食不足等因素对于改善儿童存活率至关重要.
科学领域:
- 公共卫生 公共卫生
- 营养科学 营养科学
- 儿科 儿科 儿科
背景情况:
- 关于每6个月服用维生素A补充剂降低儿童死亡率的有效性,存在相互矛盾的结果.
- 更频繁的维生素A剂量已经显示出减少缺乏人群的死亡率的承诺.
- 维生素A缺乏仍然是全球儿童的重大公共卫生问题.
研究的目的:
- 评估每6个月高剂量维生素A补充剂对儿童死亡率的影响.
- 评估维生素A和维生素E联合补充与安慰剂在高风险人群中的影响.
主要方法:
- 这是一项双盲,安慰剂控制的试验,涉及28753名苏丹9-72个月龄的儿童.
- 儿童每6个月接受20万IU维生素A与40IU维生素E或安慰剂 (40IU维生素E).
- 随访时间长达18个月,主要结果是死亡率.
主要成果:
- 维生素A和安慰剂组之间的死亡率没有显著差异 (1.06相对风险).
- 来自贫困,不卫生环境的儿童,年幼的儿童以及营养状况不佳或饮食维生素A摄入量低的儿童的死亡率明显高.
- 对各种因素的统计调整并没有改变主要发现.
结论:
- 大剂量,每6个月服用维生素A补充剂在这个人群中没有显示出死亡率的好处.
- 尽管缺乏补充剂的有效性,但观察到饮食维生素A和死亡率之间存在强烈的关联.
- 解决贫困,卫生和饮食等潜在因素对于改善儿童生存至关重要.
关键词:
非洲 非洲 非洲阿拉伯国家 阿拉伯国家生物学 生物学 生物学儿童死亡率 儿童死亡率儿童营养 儿童营养儿童生存率 儿童生存率人口结构因素 人口结构因素发展中国家 发展中国家疾病 疾病 疾病双盲研究 双盲研究经济因素 经济因素卫生健康 卫生健康 卫生健康寿命的延长 寿命的延长营养不良 营养不良疾病发病率 疾病发病率死亡率 死亡率 死亡率北非,北非,非洲北部.营养 营养 营养 营养 营养营养障碍 营养障碍 营养障碍身体生理学 身体生理学人口人口的人口人口.人口特征 人口特征人口动态 人口动态研究方法研究方法研究方法学农村人口 农村人口社会经济因素 社会经济因素研究研究研究研究研究研究.苏丹 苏丹 苏丹 苏丹幸存者的生存方式维生素A - - 管理和剂量.维生素 维生素是一种维生素.相关概念视频
Vitamins
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

